CQC to ‘pick up’ regulation of pharmacists prescribing from home

The Care Quality Commission (CQC) is set to fill the “legal loophole” that currently leaves pharmacist-owned-businesses that are run from unregistered premises completely unregulated, the pharmacy regulator has said.

“There is that regulatory gap and there's a lot of confusion around that"

The CQC is set to “absorb” the regulation of businesses where pharmacists “are not working from a registered premises”, the General Pharmaceutical Council (GPhC) today (October 13) revealed.

The announcement came after a delegate at the Pharmacy Show in Birmingham asked GPhC chief pharmacy officer and deputy registrar Roz Gittens whether the CQC “will overtake the regulation of online prescribing by pharmacists”.

Read more: GPhC fails FtP timeliness evaluation again as performance ‘deteriorates’

“We have a bit of a legal loophole at the moment” as the GPhC regulates pharmacy premises, pharmacists and pharmacy technicians “but [it doesn’t] regulate businesses,” Gittens said.

“There is that regulatory gap and there’s a lot of confusion around that,” she added.

CQC to “absorb” regulation

“The plan is that the CQC will absorb that part – so this is where we’ve got pharmacists who are not working from a registered premises,” Gittens said.

This would include businesses run by individual pharmacist prescribers who are providing a prescribing service but are not operating from a CQC or GPhC registered premises, she told C+D.

“This is where they may be setting up from a home [or] office space, whatever that may look like, but are providing clinics – typically they’re small independent companies,” she said.

Read more: CQC should replace GPhC as pharmacy premises regulator, MPs told

“It may just be that individual [so] they would still be regulated by us as an individual, but that business…our intention is the CQC will pick that up when it comes to England,” she told delegates.

But Gittins stressed that the regulatory loophole is “already covered” in Wales and Scotland.

Last month, the pharmacy regulator failed to meet its own regulator’s standards for the timely processing of fitness-to-practise (FtP) cases for the sixth year running.

Meanwhile in January, Pharmacists' Defence Association (PDA) chair Mark Koziol told MPs at the parliamentary pharmacy inquiry that the CQC should replace the GPhC as pharmacy premises regulator.

Sign in or register for free

Kate Bowie

Read more by Kate Bowie

Kate Bowie joined C+D as a digital reporter in August 2023 after graduating from a master’s in journalism at City, University of London. She began covering the primary care beat at the end of 2022, when she carried out several health investigations focused on staffing issues, NHS funding and health inequalities.

Latest from Regulation

‘Unregulated’ fat dissolver being sold in pharmacies, GPhC warns

 
• By 
 • comment0

The GPhC has issued a warning about “emerging issues” taking place in some community pharmacies including the supply of unlicensed ‘Lemon Bottle’ injections – which claim to dissolve fat – and “alternative therapy services” such as acupuncture and cupping.

Mascot on a mission to bust misconceptions about AMR

 
• By 
 • comment2

The UK Health Security Agency (UKHSA) has launched a new digital campaign led by mascot ‘Andi Biotic’ to tackle misconceptions about antibiotics and the “threat of antibiotic resistance”.

CPE hiring independent chair at £50k for 3-4 days a month

 
• By 
 • comment3

CPE is recruiting a new independent chair to “provide strategic leadership” – the position pays £50k a year and only requires a “time commitment” of 3-4 working days per calendar month.

More from News

Cutting-edge outdoor dispensing machine trialed in rural Wales

 
• By 
 • comment1

The ‘teleconsultation’ dispensing machine has pre-loaded medication ready to dispense for those in urgent need of medication when a community pharmacy is closed.

Streeting: ‘Turbulent’ Trump tariffs may hit UK medicine dispensing

 
• By 
 • comment0

The health secretary has warned that US pharmaceutical tariffs could add “another layer of challenge” to the UK’s medicine supply, and that the government may have to “take steps at the dispensing end”.